FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/07/070927 [Registered on: 19/07/2024] Trial Registered Prospectively
Last Modified On: 19/07/2024
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Case Control Study 
Study Design  Other 
Public Title of Study   Correlation between Serum Uric Acid and Urinary Uric Acid Levels in Vatarakta (Gout): Insights from Dhatwagni Siddhanta Perspective 
Scientific Title of Study   Assessment of Correlation of Serum Uric Acid and Urinary Uric Acid In Vatarakta Gout in the context of Dhatwagni Siddhant A Case Control Study 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DIGVIJAY SINGH 
Designation  P.G SCHOLAR 
Affiliation  Mahatma Gandhi Ayurved College, Hospital And Research Centre  
Address  Department of Samhita and Siddhant Division- 2 Room no- 22, MAHATMA GANDHI AYURVED COLLEGE HOSPITAL AND RESEARCH CENTRE SALOD (H) WARDHA MAHARASHTRA

Wardha
MAHARASHTRA
442001
India 
Phone  9897195260  
Fax    
Email  sdiggisingh@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Digvijay Singh  
Designation  PG Scholar 
Affiliation  MAHATMA GANDHI AYURVED COLLEGE HOSPITAL AND RESEARCH CENTRE SALOD (H) WARDHA MAHARASHTRA 
Address  Department of Samhita and Siddhant Division- 2 Room no- 22, MAHATMA GANDHI AYURVED COLLEGE HOSPITAL AND RESEARCH CENTRE SALOD (H) WARDHA MAHARASHTRA
Department of Samhita and Siddhant Division- 2 Room no- 22, MAHATMA GANDHI AYURVED COLLEGE HOSPITAL AND RESEARCH CENTRE SALOD (H) WARDHA MAHARASHTRA
Wardha
MAHARASHTRA
442001
India 
Phone  9897195260  
Fax    
Email  sdiggisingh@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Bhushan Mhaiskar  
Designation  Associate Professor 
Affiliation  MAHATMA GANDHI AYURVED COLLEGE HOSPITAL AND RESEARCH CENTRE SALOD (H) WARDHA MAHARASHTRA 
Address  Department of Samhita and Siddhant Division- 2 Room no- 22, MAHATMA GANDHI AYURVED COLLEGE HOSPITAL AND RESEARCH CENTRE SALOD (H) WARDHA MAHARASHTRA

Wardha
MAHARASHTRA
442001
India 
Phone  8983010655  
Fax    
Email  bhushan.mhaiskar@dmiher.edu.in  
 
Source of Monetary or Material Support  
Acharya Vinoba Bhave Rural Hospital Sawangi (Meghe) Wardha Maharashtra 442004 Pin - 442001 INDIA 
Mahatma Gandhi Ayurved College Hospital and Research Centre Salod(H) Wardha Maharashtra Pin - 442001 INDIA 
 
Primary Sponsor  
Name  Dr Digvijay Singh  
Address  Mahatma Gandhi Ayurved College Hospital and Research Centre Salod (H) Wardha Maharashtra Pin - 442001 INDIA 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL   
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Digvijay Singh  Mahatma Gandhi Ayurved College ,Hospital and Research Centre Wardha (Hirapur) 442001  OPD and IPD Dept of Kayachikitsa MGACH&RC Salod (H) Wardha 442001
Wardha
MAHARASHTRA 
9897195260

sdiggisingh@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Comittee Salod (H) ,Wardha-442004, Maharashtra, India  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:M206||Acquired deformities of toe(s), unspecified. Ayurveda Condition: VATARAKTAM, (2) ICD-10 Condition:M109||Gout, unspecified. Ayurveda Condition: VATARAKTAM,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
 
Inclusion Criteria  
Age From  30.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  Inclusion Criteria:
1. Patients of Age group 30-65 years irrespective of gender.
2. Provision of informed consent.
3. Confirmed diagnosis of Vatarakta (Gout) (for Group A).
 
 
ExclusionCriteria 
Details  .patients of age under 30 years and above 65 years will be excluded from the study
. Individuals with known renal or hepatic diseases.
.Pregnant or lactating women.
. Individuals who were taking NSAIDs colchicine treatment Corticoids, Anticoagulants .Diabetic Patients, Diuretics or other drugs that alter uric acid Excretion .
. Patient with hepatic insufficiency (ALT or AST above 1.5 times the upper limit of normal And serum total bilirubin more than 2 times the upper limit of normal .
. Renal insufficiency ,active peptic ulcer combined with heart disease ,Malignant tumors ,active Tuberculosis or blood disease.

 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
Generation of Empirical Data in favor of Dhatwagni Siddhant by Assessing correlation of Serum uric acid and Urinary uric acid in Vatarakta (Gout)  At Baseline 
 
Secondary Outcome  
Outcome  TimePoints 
Identifying the most critical parameters by analyzing serum uric acid & urinary uric acid in the context of Dhatwagni Siddhant in Vatarakta (Gout)  At Baseline  
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   02/08/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   The volunteers will be informed about the study protocol .Willing participants will be randomly selected as per computer generated table. Clinical research format will be prepared and Validated prior to the study approval will be taken from IEC, MGACHRC, SALOD (H) Wardha and CTRI RAGISTRATION will be done . after selection each participant will be tested individually and selected according to selection criteria . They will be divided into two groups as the case group and control group . it will include 30 patient in each group . 
Close